![Photo](/media/story/28989/thumbnail-01-sicle-cell-disease-cdc.jpg)
News • "Gene scissors" vs. sickle cell disease
FDA approves first CRISPR/Cas therapy
It's an important milestone for gene editing technology: a novel treatment for sickle cell disease utilizing CRISPR-Cas9, has now received FDA approval – a first for this type of therapy.